Cargando…
STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways
The STC2 protein involves in carcinogenesis and progression of many cancers. It remains unclear how STC2 regulates the epithelial-mesenchymal transition (EMT) process and colorectal cancer (CRC) development. Here we systematically investigated STC2-activated early occurrence of EMT and CRC cell migr...
Autores principales: | Chen, Bing, Zeng, Xiao, He, Yu, Wang, Xixi, Liang, Ziwei, Liu, Jingjing, Zhang, Peng, Zhu, Hongxia, Xu, Ningzhi, Liang, Shufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342087/ https://www.ncbi.nlm.nih.gov/pubmed/27662663 http://dx.doi.org/10.18632/oncotarget.12147 |
Ejemplares similares
-
SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways
por: Yang, Yanfang, et al.
Publicado: (2019) -
STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial–Mesenchymal Transition
por: Lin, Chen, et al.
Publicado: (2019) -
LIM protein JUB promotes epithelial–mesenchymal transition in colorectal cancer
por: Liang, Xing-Hua, et al.
Publicado: (2014) -
CHN1 promotes epithelial–mesenchymal transition via the Akt/GSK-3β/Snail pathway in cervical carcinoma
por: Zhao, Haoqi, et al.
Publicado: (2021) -
Protein SUMOylation modification and its associations with disease
por: Yang, Yanfang, et al.
Publicado: (2017)